Bioavailability pharmacokinetics and residues of marbofloxacin in normal and E.coli infected broiler chicken

 
 
 
  • Abstract
  • Keywords
  • References
  • PDF
  • Abstract


    The pharmacokinetics of marbofloxacin was studied following a single intravenous, oral administration in normal broiler chickens and repeated oral administrations in normal and experimentally E.coli infected broiler chickens. The pharmacokinetic parameters following a single intravenous injection of 2 mg/kg b.wt., revealed that marbofloxacin obeyed a two compartments open model, distribution half-life (t0.5(α)) was 0.25±0.02 h, volume of distribution (Vdss) was 0.76±0.08 L/kg, elimination half-life (t0.5(β)) was 5.43±0.87 h and total body clearance (CLtot) was 0.09±0.002 l/kg/h. Following a single oral administration, marbofloxacin was rapidly and efficiently absorbed through gastrointestinal tract of chickens as the absorption half-life (t0.5 (ab): 0.62±0.02 h). Maximum serum concentration (Cmax) was 1.15±0.01 μg/ml, reached its maximum time (tmax) at 2.53±0.04 h, elimination half-life (t0.5 (el)) was 7.36±0.20 h indicating the tendency of chickens to eliminate marbofloxacin in slow rate. Oral bioavailability was 73.57± 1.90 % indicating good absorption of marbofloxacin after oral administration. Serum concentrations of marbofloxacin following repeated oral administration of 2 mg/kg b.wt. once daily for five consecutive days, peaked 2 hours after each oral dose with lower significant values recorded in experimentally infected broiler chickens than in normal ones. Tissues residues of marbofloxacin in slaughtered normal chickens was highly in those tissues lung, liver, and kidneys in chickens and the chicken must not be slaughtered before 3 days of stopping of drug administration. It was concluded that the in- vitro protein binding was 12.33±0.82%.


  • Keywords


    Bioavailability, Broiler Chicken, Kinetic, Marbofloxacin.

  • References


      [1] Abarellos, G.A., Montoya, L. and Landoni, M.F. (2005) Pharmacokinetics of marbofloxacin after single intravenous and repeated oral administration to cats. Veterinary J,ournal, 170: 222-229. http://dx.doi.org/10.1016/j.tvjl.2004.05.011.

      [2] Abd El-Aziz, M.I., Aziza, M.A., Soliman, F.A. and Afify, N.A. (1997) Pharmacokinetic evaluation of enrofloxacin in chickens. British Poultry Science, 38: 164-168. http://dx.doi.org/10.1080/00071669708417963.

      [3] Abo El-Ela, F.I., Radi, A.M., El-Banna, H., El-Gendy, A.A.M. and Tohamy, M.A. (2014) Pharmacokinetics of difloxacin in healthy and E-coli infected broiler chickens. British Poultry Science, 55: 830-836. http://dx.doi.org/10.1080/00071668.2014.960803.

      [4] Aboubakr, M. and Abdelazem, A.M. (2015) Pharmacokinetics of marbofloxacin in Japanese quails (Coturnix japonica) after different routes of administration. Journal of American Science, 11: 136-142.

      [5] Aliabadi, F.S. and Lees, P. (2002) Pharmacokinetics and pharmacokinetic/ pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate. Journal of Veterinary Pharmacology and Therapeutics, 25: 161–174. http://dx.doi.org/10.1046/j.1365-2885.2002.00399.x.

      [6] Anadon, A., Martinez-Larranaga, M.R., Diaz, M.J., Martinez, M.A., Frejo, M.T., Martinez, M., Tafur, M. and Castellano, V.J. (2002) Pharmacokinetic characteristics and tissue residues for marbofloxacin and its metabolite N-desmethyl-marbofloxacin in broiler chickens. American Journal of Veterinary Research, 63: 927–933. http://dx.doi.org/10.2460/ajvr.2002.63.927.

      [7] Anadon, A., Martinez-Larranaga, M. R., Iturbe, J., Martinez, M.A., Diaz, M.J., Frejo, M.T. and Martinez, M. (2001) Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens. Research Veterinary Science Oct., 71: 101-119.

      [8] Atta, A.H., Sharif, L. and Yaser,G. (1997) Pharmacokinetics of levofloxacin following intravenous and oral administration in broiler chickens. Journal of Veterinary Pharmacology and Therapeutics, 20: 326-329. http://dx.doi.org/10.1046/j.1365-2885.1997.00065.x.

      [9] Baggot, J.D. (1978) some aspects of clinical pharmacokinetics in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 1: 5-18. http://dx.doi.org/10.1111/j.1365-2885.1978.tb00300.x.

      [10] Baggot, J.D. (1980) Distribution of antimicrobial agents in normal and diseased animals. J.A.V.M.A., 19: 1085-1090.

      [11] Brown, S.A. (1996) Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics, 19: 1-14. http://dx.doi.org/10.1111/j.1365-2885.1996.tb00001.x.

      [12] Carretѐro, M., Rodriguez, C., San-Andrѐs, M.I., Forѐs, P., De-Lucas, J.J., Nieto, J., Waxman, S., San-Andrѐs, M.D. and Gonzalez, F. (2002) Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration. Equine Veterinary Journal, 34: 360-365. http://dx.doi.org/10.2746/042516402776249173.

      [13] Craig, A.W. and Suh, B. (1991) Protein binding and the antibacterial effects. Method for the determination of protein binding, in: LORIAN, V. (Ed.) Antibiotics in Laboratory Medicine, 3rd edn, (Baltimore, Maryland, USA, Williams & Wilkins) pp. 367-402.

      [14] De-Lucas, J.J., Rodriguez, C., Waxman, S., Gonzàlez, F., Uriarte, I. and San-Andrѐs, M.I. (2005) Pharmacokinetics of marbofloxacin after intravenous and intramuscular to Ostriches. Veterinary Journal, 170: 364-368. http://dx.doi.org/10.1016/j.tvjl.2004.06.012.

      [15] Ding, H., Wang, L., Shen, X., Gu, X., Zeng, D. and Zeng, Z. (2013) Plasma and tissue pharmacokinetics of marbofloxacin in experimentally infected chickens with Mycoplasma gallisepticum and Escherichia coli. Journal of Veterinary Pharmacology and Therapeutics, 36: 511–515. http://dx.doi.org/10.1111/jvp.12049.

      [16] Dova, S.W., San-Andres, M.D., Gonzalez, F., San-Andres, M.I., De-Lucas, J.J. and Rodriguez, C. (2007) Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats. Veterinary Journal, 174: 425-427. http://dx.doi.org/10.1016/j.tvjl.2006.05.004.

      [17] El-Sayed, M.G.A., El-Komy, A.A.A., Aboubakr, M.H. and El-Said, A.M. (2014) Pharmacokinetics and tissue residues of norfloxacin in normal and experimentally E-coli infected broiler chickens. B.V.M.J., 26: 10-18.

      [18] Garcia-Montijano, M., de Lucas, J.J., Rodríguez, C., González, F., San Andrés, M.I. and Waxman, S. (2012) Marbofloxacin disposition after intravenous administration of a single dose in wild mallard ducks. Journal of Avian Medicine and Surgery, 26: 6-10. http://dx.doi.org/10.1647/2011-007.1.

      [19] Garica-Montijano, M., De-Lucas, J.J., Rodriguez, C., Gonzalez, F., De San-Andrѐs, M.I. and Waxman, S. (2012) Marbofloxacin disposition after intravenous administration of a single dose in wild mallard ducks (Anas Platyrhynchos). Journal of Avian Medicine and Surgery, 26: 6-10. http://dx.doi.org/10.1647/2011-007.1.

      [20] Gouda, A. (2009) Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens. British Poultry Science, 50: 251-258. http://dx.doi.org/10.1080/00071660802710108.

      [21] Goudah, A. and Hasabelnaby, S. (2010) the disposition of marbofloxacin after single dose intravenous, intramuscular and oral administration to Muscovy ducks after. Journal of Veterinary Pharmacology and Therapeutics, 34: 197-201. http://dx.doi.org/10.1111/j.1365-2885.2010.01225.x.

      [22] Goudah, A. and Mouneir, S.M. (2009) Disposition kinetics and tissue residues of danofloxacin in Muscovy ducks. British Poultry Science, 50: 613-619. http://dx.doi.org/10.1080/00071660903147416.

      [23] Haddad, N.S., Pedersol, J.P., Ravis, W.R., Fazel, M.H. and Carson, R.L. (1985) Pharmacokinetics of gentamicin at steady-state in ponies, serum, urine and endometrial concentration. American Journal of Veterinary Research, 46: 1268-1271.

      [24] Haritova, A.M., Rusenova, N.V., Parvanov, P.R., Lashev, L.D. and Fink-Gremmels, J. (2006) Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys. Antimicrobial Agents Chemotherapy, 50: 3779-3785. http://dx.doi.org/10.1128/AAC.00711-05.

      [25] Intorre L., Mengozzi, G., Bertini, S., Bagliacca, M., Luchetti, E. and Soldani, G. (1997)the plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Muscovy duck. Veterinary Research Communication, 21: 127-136. http://dx.doi.org/10.1023/A:1005773603905.

      [26] Ismail, M. and El-Kattan, Y.A. (2007) Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves. Research in Veterinary Science, 82: 398–404. http://dx.doi.org/10.1016/j.rvsc.2006.10.001.

      [27] Kalaiselvi, L., Sriranjani, D., Ramesh, S., Sriram, P. and Mathuram, L.N. (2006) Pharmacokinetics of ofloxacin in broiler chicken. Journal of Veterinary Pharmacology and Therapeutics, 29:185-189. http://dx.doi.org/10.1111/j.1365-2885.2006.00729.x.

      [28] Mevius, D.J., Breukink, H.J., Guelen, P.J.M., Jansen, T.D. and Greve, B.C. (1990: Pharmacokinetics, metabolism and renal clearance of flumequine in veal calves. Journal of Veterinary Pharmacology and Therapeutics, 13: 159-169. http://dx.doi.org/10.1111/j.1365-2885.1990.tb00764.x.

      [29] Park, S.C., Yun, H.I. and Oh, T.K. (1998) Comparative pharmacokiretic profiles of two norfloxacin formulation after oral administration in rabbits. Journal of Veterinary Medicine and Science, 60: 661-663. http://dx.doi.org/10.1292/jvms.60.661.

      [30] Preheim, L., Cuevas, T., Roccaforte, J., Mellencamp, M. and Bittner, M. (1987) Oral use of ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/ sulfamethoxazole-resistant bacteria. American Journal of Medicine, 82: 295–297.

      [31] Salehi, T.Z., Tabatabaei, S., Karimi, V., Fasaei, B.N., Derakhshandeh, A. and Jahromi, A.O. 2012 Assessment of immunity against avain colibacillosis induced by an aroA mutant containing increased serum survival gene in broilers. Brazilian Journal Microbiology, 43: 363-370. http://dx.doi.org/10.1590/S1517-83822012000100043.

      [32] Schneider, M., Paulin, A., Dron, F. and Woehrlѐ, F. (2014) Pharmacokinetics of marbofloxacin in pigs after intravenous and intramuscular administration of a single dose of 8 mg/ kg : dose proportionality, influence of the age of animals and urinary elimination. Journal of Veterinary Pharmacology and Therapeutics, 37: 523-530. http://dx.doi.org/10.1111/jvp.12125.

      [33] Schneider, M., Thomas, V., Boisrame, B. and Deleforge, J. (1996) Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration. Journal of Veterinary Pharmacology and Therapeutics, 19: 56–61. http://dx.doi.org/10.1111/j.1365-2885.1996.tb00009.x.

      [34] Snedecor, G.W. and Cochran, T. (1976) “Statistical Methods” 6th ed. pp. Ames, lowa U.S.A., 502-503.

      [35] Soliman, G.A. (2000) Tissue distribution and disposition kinetics of enrofloxacin in healthy and E-coli infected broilers. Dtsch. Tierärztl. Wochenschr., 107: 23-27.

      [36] Spreng, M., Deleforge, J., Thomas, V., Boisrame, B. and Drugeon, H. (1995) Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics, 18: 284–289. http://dx.doi.org/10.1111/j.1365-2885.1995.tb00592.x.

      [37] Tohamy, M.A. and El-Gendy, A.A.M. (2013) some pharmacokinetic aspects and bioavailability of marbofloxacin in foals. Beni-Suef University Journal of Basic and Applied Science, 2: 46-50. http://dx.doi.org/10.1016/j.bjbas.2013.09.007.

      [38] Tsai, C.E. and Kondo, F. (2001) Improved agar diffusion method for detecting residual antimicrobial agents. Journal of Food Proectiont, 64: 361-366.

      [39] Varia, D., Patel, H., Patel, U. D., Bhavsar, K. and Thaker, M. (2009) Disposition of levofloxacin following oral administration in broiler chickens. ISRAEL JOURNAL OF VETERINARY MEDICINE, 64:118-121.

      [40] Waxman, S., San-Andrѐs, M.D., Gonzàlez, F., San-Andres, M.I., De-Lucas, J.J. and Rodriguez, C. (2004) Age-related changes in the pharmacokinetics of marbofloxacin after intravenous administration in goats. Journal of Veterinary Pharmacology and Therapeutics, 27: 31-35. http://dx.doi.org/10.1111/j.1365-2885.2004.00548.x.

      [41] Wolfson, J.S. and Hooper, D.C. (1985) the fluroquinolones: structures, mechanism of action and resistance and spectra of activity in vitro. Antimicrobial Agents Chemotherapy, 28: 581-586. http://dx.doi.org/10.1128/AAC.28.4.581.

      [42] Yang, F., Yang, Y.R., Wang, L., Huang, X.H., Qiao, G. and Zeng, Z.L. (2014) Estimating marbofloxacin withdrawal time in broiler chickens using a population physiologically based pharmacokinetics model. Journal of Veterinary Pharmacology and Therapeutics, 37: 579-588. http://dx.doi.org/10.1111/jvp.12137.

      [43] Yamaoka, K., Nakagawa, T. and Uno, T. (1978) Statistical moment in pharmacokinetics. Journal of Pharmacokinetic and Biopharmaceutics, 6: 547-558. http://dx.doi.org/10.1007/BF01062109.

      [44] Yuan, L.G., Wang, R., Sun, L.H., Zhu, L.X., Luo, X.Y., Sun, J., Fang, B.H. and Liu, Y.H. (2011) Pharmacokinetics of marbofloxacin in Muscovy ducks (Cairina moschata). Journal of Veterinary Pharmacology and Therapeutics, 34: 82- 85. http://dx.doi.org/10.1111/j.1365-2885.2010.01207.x.

      [45] Zlotos, G., Bucker, A., Kinzing-Schippers, M., Sorgel, F. and Holzgrabe, U. (1998) Plasma protein binding of gyrase inhibitors. Journal of Pharmaceutical Scence, 87: 215-220. http://dx.doi.org/10.1021/js970181b.


 

View

Download

Article ID: 6504
 
DOI: 10.14419/ijpt.v4i2.6504




Copyright © 2012-2015 Science Publishing Corporation Inc. All rights reserved.